In humans, CBD also inhibits the activity of MRP1 in ovarian cancer cells [72], while inducing BCRP expression and reducing MDR1 expression in human trophoblast-like cell lines, BeWo and Jar [73]. This evidence concerns the gene ABCG2 and ovarian carcinoma.